CD8A and melanoma: Co-electroporation of TriMixDC with mRNA encoding a fusion of melanoma antigen and DC-LAMP, an approach named TriMixDC-MEL, stimulated antigen-specific CD8+ T and Th1 cells in vaccinated patients (Bonehill et al., 2009).